Abrahams said she had a conversation recently with an elderly man called Nigel. “He has no food in his house but he is scared to leave it because of coronavirus,” she said. “Nigel isn’t online. He was recently discharged from hospital but no longer gets any support at home. Nigel was told that food parcels would be delivered but has only received one some time ago. He is now out of food and has no family or friends who can help him.”
“Children’s lives are being upended across the globe – their support systems ripped away, their borders closed, their educations lost, their food supply cut off. Even in the UK, children face the threat of a measles outbreak and school closures are putting vulnerable children at increased risk.” said Unicef UK’s executive director Sacha Deshmukh.
https://www.theguardian.com/global-development/2020/may/13/unicef-6000-children-could-die-every-day-due-to-impact-of-coronavirus
The world’s nuclear-armed nations spent a record $73bn on their weapons last year, with the US spending almost as much as the eight other states combined, according to a new report.
The new spending figures, reflecting the highest expenditure on nuclear arms since the height of the cold war, have been estimated by the International Campaign to Abolish Nuclear Weapons (Ican), which argues that the coronavirus pandemic underlines the wastefulness of the nuclear arms race.
The nine nuclear weapons states spent a total of $72.9bn in 2019, a 10% increase on the year before. Of that, $35.4bn was spent by the United States, which accelerated the modernisation of the US arsenal while cutting expenditure on pandemic prevention.
“It’s clear now more than ever that nuclear weapons do not provide security for the world in the midst of a global pandemic, and not even for the nine countries that have nuclear weapons, particularly when there are documented deficits of healthcare supplies and exhausted medical professionals,” Alicia Sanders-Zakre, the lead author of the report, said.
https://www.theguardian.com/world/2020/may/13/nuclear-weapons-world-record-spending
Pharmaceutical companies often defend their pricing by claiming that their costs are incredibly high. However, when calculating the price of a generic version of the drug, the researchers factored in export costs, taxes and even a 10% profit margin. In some cases, pharmaceutical companies have minimised their costs by receiving government subsidies.
Pirfenidone, a drug used for lung fibrosis, costs around $31 for a 28-day treatment course. In the US, a course is priced at $9,606, or $6,513 if patients are able to access it through the Department of Veterans Affairs. Though the US tops the list, the list price of this drug is still expensive elsewhere – a course costs $2,561 in the UK and $2,344 in France.
Gilead Sciences, the company that makes Remdesivir, a drug which has been touted by the US government’s top infectious disease expert, Dr Anthony Fauci, benefited from at least $79m in US government funding. Despite the fact that US taxpayers have helped to develop the drug, Gilead announced it would no longer provide emergency access to it. Then, after widespread criticism, the company back-tracked this week and said it would donate its entire stockpile of the drug to government. In late March, the Food and Drug Administration gave Gilead “orphan” drug status, meaning the company has the right to profit exclusively for seven years from the sale of remdesivir. Normally, this drug status is reserved for treating rare diseases, not ones such as as Covid-19, for which more than 1 million people in the US have tested positive (and many more have been infected but not tested). Gilead, which made $5bn in profit last year, has close ties to the US administration. Between 2011 and 2017, Joe Grogan lobbied for Gilead. He now serves on the White House coronavirus taskforce.
https://www.theguardian.com/world/2020/may/11/soaring-drug-prices-could-bar-access-to-future-coronavirus-treatments